May 2008
EW WEEK Vol. 13 No. 13
·
Pfizer drops trials of NicOx glaucoma drug
·
RegenRx awarded patent in Hong Kong
·
FDA grants request to expand Neovista’s CABERNET trial
·
Bepreve demonstrates efficacy in Phase III trial
View this Issue
Would you like to receive EyeWorld Week?
Monthly Poll
Do you believe glistenings can become severe enough to affect a patient’s visual acuity?
Yes
No
[
Results
|
Polls
]
Votes:
15
|Comments:
0
Resources
Ophthalmologists
Practice Managers
Consumers
NYU-ASCRS Podcasting
EyeSpaceMD
Subscription Request Form
Please fill out the following information and click the submit button when finished.
First Name:
Last Name:
Suffix:
Street Address:
City:
State:
Zip:
Country:
Email Address:
Phone Number:
Fax Number:
Please check the subspecialty(s) that apply to you.
Cataract Surgery
Refractive Surgery
General Ophthalmology
Glaucoma
Cornea/External Disease
Vitreous/Retina
Pediatrics
Oculoplastics
Pathology
All of the above
None of the above
Other
I am a Practicing Ophthalmologists who are resides in the United States
Contribute
|
Editorial Board
|
Advertiser Index
|
Publishing Statement
|
Advertise with Us
Copyright © 1997-2008 EyeWorld News Service
Visit
EyeWorld.mobi
for a PDA optimized experience